Literature DB >> 11177544

Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column.

A Auricchio1, M Hildinger, E O'Connor, G P Gao, J M Wilson.   

Abstract

One of the most promising gene transfer vectors in human clinical trials is AAV2. The quality of the vector preparations is a key element in obtaining reliable and reproducible data in preclinical studies. However, established protocols either result in impure, low infectious virus (CsCl2 gradient centrifugation) or demand a high level of manual and technical skills (CsCl2 gradient centrifugation, iodixanol/heparin or HPLC purification). In this study, we present an easy-to-do single-step column purification (SSCP) of AAV2 by gravity flow based on its affinity to heparin, without ultracentrifugation. Various vector preparations generated by our method reproducibly showed high titers, infectivity, and purity. In vivo, our single-step column-purified AAV2 vectors mediate significantly higher transduction efficiency compared with conventional protocols. Investigators still unsatisfied with previously published techniques or new to the field of AAV production may find in our method an interesting alternative.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11177544     DOI: 10.1089/104303401450988

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  93 in total

1.  Characterization of anti-HIV activity mediated by R88-APOBEC3G mutant fusion proteins in CD4+ T cells, peripheral blood mononuclear cells, and macrophages.

Authors:  Zhujun Ao; Xiaoxia Wang; Alexander Bello; Kallesh Danappa Jayappa; Zhe Yu; Keith Fowke; Xinying He; Xi Chen; Junhua Li; Gary Kobinger; Xiaojian Yao
Journal:  Hum Gene Ther       Date:  2011-03-18       Impact factor: 5.695

2.  CD151 gene delivery activates PI3K/Akt pathway and promotes neovascularization after myocardial infarction in rats.

Authors:  Zhenzhong Zheng; Zhengxiang Liu
Journal:  Mol Med       Date:  2006 Sep-Oct       Impact factor: 6.354

3.  Delivery of recombinant adeno-associated virus-mediated human tissue kallikrein for therapy of chronic renal failure in rats.

Authors:  Ling Tu; Xizhen Xu; Huaibing Wan; Changqing Zhou; Juanjuan Deng; Gang Xu; Xiao Xiao; Yipu Chen; Matthew L Edin; James W Voltz; Darryl C Zeldin; Dao Wen Wang
Journal:  Hum Gene Ther       Date:  2008-04       Impact factor: 5.695

4.  Tissue kallikrein reverses insulin resistance and attenuates nephropathy in diabetic rats by activation of phosphatidylinositol 3-kinase/protein kinase B and adenosine 5'-monophosphate-activated protein kinase signaling pathways.

Authors:  Gang Yuan; Juanjuan Deng; Tao Wang; Chunxia Zhao; Xizheng Xu; Peihua Wang; James W Voltz; Matthew L Edin; Xiao Xiao; Lee Chao; Julie Chao; Xin A Zhang; Darryl C Zeldin; Dao Wen Wang
Journal:  Endocrinology       Date:  2007-02-01       Impact factor: 4.736

5.  Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity.

Authors:  Joseph E Rabinowitz; Fabienne Rolling; Chengwen Li; Hervè Conrath; Weidong Xiao; Xiao Xiao; R Jude Samulski
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

6.  A simplified baculovirus-AAV expression vector system coupled with one-step affinity purification yields high-titer rAAV stocks from insect cells.

Authors:  Richard H Smith; Justin R Levy; Robert M Kotin
Journal:  Mol Ther       Date:  2009-06-16       Impact factor: 11.454

7.  Expression of transgenes in midbrain dopamine neurons using the tyrosine hydroxylase promoter.

Authors:  M S Oh; S J Hong; Y Huh; K-S Kim
Journal:  Gene Ther       Date:  2008-09-18       Impact factor: 5.250

8.  Multiple recombinant adeno-associated viral vector serotypes display persistent in vivo gene expression in vector-transduced rat stifle joints.

Authors:  Jeffrey B Mason; Brittney L Gurda; Julie B Engiles; Kurt D Hankenson; James M Wilson; Dean W Richardson
Journal:  Hum Gene Ther Methods       Date:  2013-06       Impact factor: 2.396

9.  Muscle-directed gene therapy for hemophilia B with more efficient and less immunogenic AAV vectors.

Authors:  L Wang; J-P Louboutin; P Bell; J A Greig; Y Li; D Wu; J M Wilson
Journal:  J Thromb Haemost       Date:  2011-10       Impact factor: 5.824

10.  CD151 gene delivery after myocardial infarction promotes functional neovascularization and activates FAK signaling.

Authors:  Houjuan Zuo; Zhengxiang Liu; Xiaochun Liu; Jun Yang; Tao Liu; Sha Wen; Xin A Zhang; Katherine Cianflone; Daowen Wang
Journal:  Mol Med       Date:  2009-06-18       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.